Exquisite sensitivity of adrenocortical carcinomas to induction of ferroptosis
- PMID: 31611400
- PMCID: VSports - PMC6825277
- DOI: "V体育2025版" 10.1073/pnas.1912700116
Exquisite sensitivity of adrenocortical carcinomas to induction of ferroptosis
Abstract
Adrenocortical carcinomas (ACCs) are rare and highly malignant cancers associated with poor survival of patients. Currently, mitotane, a nonspecific derivative of the pesticide DDT (1,1-(dichlorobiphenyl)-2,2-dichloroethane), is used as the standard treatment, but its mechanism of action in ACCs remains elusive. Here we demonstrate that the human ACC NCI-H295R cell line is remarkably sensitive to induction of ferroptosis, while mitotane does not induce this iron-dependent mode of regulated necrosis. Supplementation with insulin, transferrin, and selenium (ITS) is commonly used to keep NCI-H295R cells in cell culture. We show that this supplementation prevents spontaneous ferroptosis, especially when it contains polyunsaturated fatty acids (PUFAs), such as linoleic acid. Inhibitors of apoptosis (zVAD, emricasan) do not prevent the mitotane-induced cell death but morphologically prevent membrane blebbing. The expression of glutathione peroxidase 4 (GPX4) in H295R cells, however, is significantly higher when compared to HT1080 fibrosarcoma cells, suggesting a role for ferroptosis. Direct inhibition of GPX4 in H295R cells led to high necrotic populations compared to control, while cotreatment with ferrostatin-1 (Fer-1) completely reverted ferroptosis. Interestingly, the analysis of public databases revealed that several key players of the ferroptosis pathway are hypermethylated and/or mutated in human ACCs. Finally, we also detected that growth hormone-releasing hormone (GHRH) antagonists, such as MIA602, kill H295R cells in a nonapoptotic manner. In summary, we found elevated expression of GPX4 and higher sensitivity to ferroptosis in ACCs. We hypothesize that instead of treatment with mitotane, human adrenocortical carcinomas may be much more sensitive to induction of ferroptosis VSports手机版. .
Keywords: adrenal; adrenocortical carcinoma; endocrine tumors; ferroptosis; regulated necrosis V体育安卓版. .
Conflict of interest statement
Competing interest statement: S. R. B. and A. V V体育ios版. S. hold patents on MIA602. A. V. S. patents are assigned to the University of Miami and Veterans Affairs. Reviewer W. K. was a coauthor with A. L. on this manuscript on a 2018 paper that is a committee report. Apart from this, all authors declare no competing interest regarding any of the presented data in this manuscript.
Figures (VSports最新版本)
"V体育官网" References
-
- Fassnacht M., Libé R., Kroiss M., Allolio B., Adrenocortical carcinoma: A clinician’s update. Nat. Rev. Endocrinol. 7, 323–335 (2011). - PubMed (VSports最新版本)
-
- Megerle F., Kroiss M., Hahner S., Fassnacht M., Advanced adrenocortical carcinoma—What to do when first-line therapy fails? Exp. Clin. Endocrinol. Diabetes 127:109–116 (2019). - V体育安卓版 - PubMed
-
- Tierney J. F., et al. , National treatment practice for adrenocortical carcinoma: Have they changed and have we made any progress? J. Clin. Endocrinol. Metab., jc.2019-00915 (2019). - "VSports最新版本" PubMed
-
- Giordano T. J., et al. , Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling. Clin. Cancer Res. 15, 668–676 (2009). - VSports注册入口 - PMC - PubMed
-
- Zheng S., et al. ; Cancer Genome Atlas Research Network , Comprehensive pan-genomic characterization of adrenocortical carcinoma. Cancer Cell 30, 363 (2016). - "V体育官网" PubMed
VSports在线直播 - Publication types
MeSH terms
- "V体育ios版" Actions
- VSports最新版本 - Actions
- Actions (VSports最新版本)
- "VSports在线直播" Actions
- "VSports" Actions
Substances
- "VSports最新版本" Actions
- Actions (VSports最新版本)
- Actions (VSports app下载)
- Actions (VSports手机版)
- Actions (VSports手机版)
LinkOut - more resources
Full Text Sources
Miscellaneous
